Intrathecal Pumps; Often Used to Deliver Pain Medication Directly to the Spinal Cord

Intrathecal Pumps
Intrathecal Pumps

An Intrathecal Pumps is a medical device that can deliver medication directly into the spinal fluid. It is usually used for patients with chronic pain. It is also used to treat severe spasticity. The pump is a battery-operated, programmable device. It has two parts: a pump and a catheter. It can be set up to release medication at a specific time of day or at a fixed rate. It is placed in an incision made in the lower half of the abdomen. 

A smaller incision is made in the back to place the catheter. The surgeon will perform a series of procedures to implant the pump system. An intrathecal pain pump implant is a way to relieve some kinds of long-term (chronic) pain or cancer pain. It sends pain medicine through a thin, flexible tube. The tube is inserted into the space around the spinal cord. 

Since analgesics make up the majority of the medications administered by  pumps, pain management holds the biggest Intrathecal Pumps Market share, followed by spasticity management.

Pump allows precise and sustained release of medication to get rid of various chronic conditions namely multiple sclerosis and cancer pain. An pump and catheters are implanted surgically to deliver medication directly into the spinal cord, which in turn offers dramatic pain management. 

Intrathecal Pumps are portable, accurate, easy to use, and also consume very less power. They are used in the treatment of many medical conditions, but the most common use for this product is in the treatment of severe pain associated with disease such as multiple sclerosis, rheumatoid arthritis, osteoarthritis, shingles, meningitis, encephalitis, stroke, and diabetes.

The pump works by injecting the medication directly into the tissues. Pumps can be appropriate for people living with severe, chronic pain or spasticity that is not controlled with other methods. Thus, there is an increase in demand for them worldwide. In February 2020, Flowonix Medical, Inc. received the U.S. Food and Drug Administration (USFDA) approval to market the Prometra II Programmable Pump System for use with intrathecal baclofen.

Comments

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

U.S. FDA Has Approved Several Colon and Rectal Cancer Drugs to Treat Colon and Rectal Cancer

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care